News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Medarex, Inc. CEO Got 91% Pay Raise Despite Delivering Nothing
April 10, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BNET -- If there’s a pharma company that rewards executives for delivering absolutely nothing, thy name is Medarex. Consider its record in 2008:
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
·
2 min read
·
Tristan Manalac
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
September 4, 2025
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
September 3, 2025
·
2 min read
·
Tristan Manalac
FDA
Offit Out at FDA Vaccine Advisory Committee After HHS Rebuff
September 2, 2025
·
3 min read
·
Heather McKenzie
